J&J to pay more to settle suits over hip implants
Its DePuy unit agrees to extend deadline for new settlements over defective devices, pushing total compensation to US$3b
Delaware
JOHNSON & Johnson agreed to pay as much as US$420 million more to resolve lawsuits over recalled hip implants that were excluded in 2013 from a US$2.5 billion settlement of claims that the devices were defective and caused metal poisoning in patients.
J&J's DePuy unit agreed to push back the deadline for recipients of the company's ASR implants to file settlement claims to Jan 31 of this year, according to a filing Friday in federal court in Toledo, Ohio. That will allow as many as 1,400 patients who've had ASR hips removed since 2013 to seek about US$300,000 each in compensation under the original 2013 accord.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Jim Beam owner bets on canned vodka cocktails to double revenue
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Cordlife served letter of demand, notice of claim from customers
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs